GPCR Therapeutics Announces Publication in PNAS Using Cutting Edge Spectroscopy to Detect GPCR Heteromers on Live Cancer Cells
- Further validates company’s dual GPCR targeting approach SEOUL, South Korea & REDWOOD CITY, Calif.--(BUSINESS WIRE)--#CXCR4--GPCR Therapeutics, Inc., a clinical-stage,...


















